In an effort to combine quantitative and qualitative measures of immunity, Riou et al. [59] evaluated the impact of the quantity, quality and specificity of CD8+ T cell responses at approximately six months post-infection on the viral set point at 12 months in a cohort of HIV-1-infected individuals in South Africa. The gene discussed is CD8A; the disease is infection.